Literature DB >> 25527793

Mechanisms of Jak/STAT signaling in immunity and disease.

Alejandro V Villarino1, Yuka Kanno1, John R Ferdinand1, John J O'Shea2.   

Abstract

More than two decades ago, experiments on the antiviral mechanisms of IFNs led to the discovery of JAKs and their downstream effectors, the STAT proteins. This pathway has since become a paradigm for membrane-to-nucleus signaling and explains how a broad range of soluble factors, including cytokines and hormones, mediate their diverse functions. Jak/STAT research has not only impacted basic science, particularly in the context of intercellular communication and cell-extrinsic control of gene expression, it also has become a prototype for transition from bench to bedside, culminating in the development and clinical implementation of pathway-specific therapeutics. This brief review synthesizes our current understanding of Jak/STAT biology while taking stock of the lessons learned and the challenges that lie ahead.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25527793      PMCID: PMC4524500          DOI: 10.4049/jimmunol.1401867

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ.

Authors:  Andreas Begitt; Mathias Droescher; Klaus-Peter Knobeloch; Uwe Vinkemeier
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

Authors:  Katrin Friedbichler; Marc A Kerenyi; Boris Kovacic; Geqiang Li; Andrea Hoelbl; Saliha Yahiaoui; Veronika Sexl; Ernst W Müllner; Sabine Fajmann; Sabine Cerny-Reiterer; Peter Valent; Hartmut Beug; Fabrice Gouilleux; Kevin D Bunting; Richard Moriggl
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

3.  Cell signaling. Stat acetylation--a key facet of cytokine signaling?

Authors:  John J O'Shea; Yuka Kanno; Xiaomin Chen; David E Levy
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

4.  Arginine methylation of STAT1: a reassessment.

Authors:  Torsten Meissner; Eberhard Krause; Inga Lödige; Uwe Vinkemeier
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

5.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 6.  Genomic views of STAT function in CD4+ T helper cell differentiation.

Authors:  John J O'Shea; Riitta Lahesmaa; Golnaz Vahedi; Arian Laurence; Yuka Kanno
Journal:  Nat Rev Immunol       Date:  2011-04       Impact factor: 53.106

Review 7.  Cytokine signaling modules in inflammatory responses.

Authors:  John J O'Shea; Peter J Murray
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

8.  Selective inhibition of the function of tyrosine-phosphorylated STAT3 with a phosphorylation site-specific intrabody.

Authors:  Mi Young Koo; Jiyoung Park; Jung Mi Lim; Sei Yoon Joo; Seung-Pil Shin; Hyun Bo Shim; Junho Chung; Dongmin Kang; Hyun Ae Woo; Sue Goo Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

Review 9.  Discovering susceptibility genes for asthma and allergy.

Authors:  Donata Vercelli
Journal:  Nat Rev Immunol       Date:  2008-03       Impact factor: 53.106

10.  Genome-wide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes.

Authors:  Bing-Mei Zhu; Keunsoo Kang; Ji Hoon Yu; Weiping Chen; Harold E Smith; Daeyoup Lee; Hong-Wei Sun; Lai Wei; Lothar Hennighausen
Journal:  Nucleic Acids Res       Date:  2012-02-08       Impact factor: 16.971

View more
  150 in total

1.  Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

2.  JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer.

Authors:  Chunwan Lu; Asif Talukder; Natasha M Savage; Nagendra Singh; Kebin Liu
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

3.  Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Authors:  Jiping Zhao; Hao Yu; Yudong Liu; Sara A Gibson; Zhaoqi Yan; Xin Xu; Amit Gaggar; Pui-Kai Li; Chenglong Li; Shi Wei; Etty N Benveniste; Hongwei Qin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

Review 4.  Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplant.

Authors:  Michael Byrne; Bipin Savani; Michael R Savona
Journal:  Ther Adv Hematol       Date:  2018-07-16

5.  Cytokine exocytosis and JAK/STAT activation in the Drosophila ovary requires the vesicle trafficking regulator α-Snap.

Authors:  Afsoon Saadin; Michelle Starz-Gaiano
Journal:  J Cell Sci       Date:  2018-11-30       Impact factor: 5.285

6.  STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells.

Authors:  Sonia S Majri; Jill M Fritz; Alejandro V Villarino; Lixin Zheng; Chrysi Kanellopoulou; Benjamin Chaigne-Delalande; Juha Grönholm; Julie E Niemela; Behdad Afzali; Matthew Biancalana; Stefania Pittaluga; Ashleigh Sun; José L Cohen; Steven M Holland; John J O'Shea; Gulbu Uzel; Michael J Lenardo
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

7.  Genomic and Genetic Approaches to Deciphering Acute Respiratory Distress Syndrome Risk and Mortality.

Authors:  Heather Lynn; Xiaoguang Sun; Nancy Casanova; Manuel Gonzales-Garay; Christian Bime; Joe G N Garcia
Journal:  Antioxid Redox Signal       Date:  2019-06-18       Impact factor: 8.401

8.  Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastava; Snahlata Singh; Ajeya Nandi; Gatha Thacker; Hemma Murali; Sabrina Kim; Mary Baldeon; John Tobias; Mario Andres Blanco; Rizwan Saffie; M Raza Zaidi; Satrajit Sinha; Luca Busino; Serge Y Fuchs; Rumela Chakrabarti
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

Review 9.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

Review 10.  Signal transducer and activator of transcription 3: a year in review.

Authors:  Lisa R Forbes; Josh Milner; Elie Haddad
Journal:  Curr Opin Hematol       Date:  2016-01       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.